An official website of the United States government
Home
Name
Vistogard
Alternate Names
uridine triacetate
Abbreviations
None
Category
Ancillary Agent
Subcategory
None
NSC Number
None
Primary Site
None
Histology
None
Remarks
December 11, 2015: The FDA approved Vistogard for the emergency treatment of adults children who receive an overdose of the cancer treatment fluoroucil or capecitabine, or who develop certain severe or life-threatening toxicities within four days of receiving these cancer treatments.
Coding
This drug should NOT be coded
